NEJM at ESC - Asundexian versus Apixaban in Patients with Atrial Fibrillation No … ← NEJM at ESC - Inflammation, Cholesterol, Lipoprotein(a) and 30-Year Cardiovascular Outcomes in Women NEJM at ESC - Asundexian versus Apixaban in Patients with Atrial Fibrillation →